Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

EXACT Therapeutics AS (56F.F)

Compare
0.2840
+0.0140
+(5.19%)
As of 8:14:09 AM GMT+1. Market Open.
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
48,379.2890
48,379.2890
40,774.7680
59,110.8250
34,698.6610
Operating Income
-48,379.2890
-48,379.2890
-40,774.7680
-59,110.8250
-34,698.6610
Net Non Operating Interest Income Expense
1,113.9140
1,113.9140
-15.0820
513.6890
958.6540
Pretax Income
-48,382.1620
-48,382.1620
-40,566.4770
-58,590.1810
-33,085.4680
Tax Provision
-48.4730
-48.4730
-462.0820
--
--
Net Income Common Stockholders
-48,333.6910
-48,333.6910
-40,104.3950
-58,590.1810
-33,085.4680
Diluted NI Available to Com Stockholders
-48,333.6910
-48,333.6910
-40,104.3950
-58,590.1810
-33,085.4680
Basic EPS
-1.51
-1.51
-1.34
-1.95
-2.20
Diluted EPS
-1.51
-1.51
-1.34
-1.95
-2.20
Basic Average Shares
32,080.5520
32,080.5520
29,997.2190
29,979.9590
15,028.8310
Diluted Average Shares
32,080.5520
32,080.5520
29,997.2190
29,979.9590
15,028.8310
Total Operating Income as Reported
-48,379.2900
-48,379.2900
-40,774.7680
-59,110.8240
-34,698.6610
Rent Expense Supplemental
241.6120
241.6120
465.1950
530.3430
488.8050
Total Expenses
48,379.2890
48,379.2890
40,774.7680
59,110.8250
34,698.6610
Net Income from Continuing & Discontinued Operation
-48,333.6910
-48,333.6910
-40,104.3950
-58,590.1810
-33,085.4680
Normalized Income
-48,333.6910
-48,333.6910
-40,104.3950
-58,590.1810
-33,038.1640
Interest Income
945.0230
945.0230
479.3700
339.7060
65.2100
Interest Expense
85.6350
85.6350
98.9270
100.1090
23.6190
Net Interest Income
1,113.9140
1,113.9140
-15.0820
513.6890
958.6540
EBIT
-48,296.5270
-48,296.5270
-40,467.5500
-58,490.0720
-33,061.8490
EBITDA
-46,204.6430
-46,204.6430
-38,464.5960
-56,660.0880
-31,983.5850
Reconciled Depreciation
2,091.8840
2,091.8840
1,936.0820
1,829.9840
902.6470
Net Income from Continuing Operation Net Minority Interest
-48,333.6910
-48,333.6910
-40,104.3950
-58,590.1810
-33,085.4680
Total Unusual Items Excluding Goodwill
--
--
--
--
-47.3040
Total Unusual Items
--
--
--
--
-47.3040
Normalized EBITDA
-46,204.6430
-46,204.6430
-38,464.5960
-56,660.0880
-31,936.2810
Tax Rate for Calcs
0
0
0
--
--
12/31/2020 - 5/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ONCIN.OL Oncoinvent ASA
1.7000
+6.25%
 
ULTI.OL Zelluna ASA
2.0500
0.00%
 
ABLI.ST Abliva AB (publ)
0.4500
-0.22%
 
NYKD.OL Nykode Therapeutics AS
2.1080
-1.96%
 
CTNM Contineum Therapeutics, Inc.
6.10
-2.40%
 
BGBIO.OL BerGenBio ASA
1.6200
-1.09%